Literature DB >> 27424472

Stent-Assisted Coiling of 501 Wide-Necked Intracranial Aneurysms: A Single-Center 8-Year Experience.

Yongtao Zheng1, Yanbing Song1, Yingjun Liu1, Qiang Xu2, Yanlong Tian1, Bing Leng3.   

Abstract

BACKGROUND: Stent-assisted coiling has expanded the treatment of complex wide-necked intracranial aneurysms. We present our experience with stent-assisted coiling, with an emphasis on procedure-related neurologic complications and the incidence of angiographic recurrence.
METHODS: A total of 480 patients with 501 aneurysms who were treated with stent-assisted coiling between January 2007 and December 2014 were reviewed retrospectively. Baseline characteristics, procedure-related complications, angiographic follow-up results, and clinical outcomes were statistically analyzed.
RESULTS: Among the 480 patients, 423 (88%) were treated electively and 57 (11%) were treated in the context of subarachnoid hemorrhage. There were 22 (4.58%) overall procedure-related complications, which caused death in 4 patients (0.83%) and morbidity in 4 patients (0.83%). In a logistic regression analysis, the complications differed significantly among the patients with hypertension (odds ratio [OR], 2.85; 95% confidence interval [CI], 1.09-7.48; P = 0.03), patients with aneurysms treated with coiling before stenting (OR, 3.07; 95% CI, 1.07-8.81; P = 0.04), and patients treated with multiple stents (OR, 4.96; 95% CI, 1.02-24.07; P = 0.04). Angiographic follow-up was available for 396 patients (83.4%) for a mean of 13 months. The rates of recanalization and retreatment were 13.9% and 3.5%, respectively. In a logistic analysis, larger aneurysm size and initial incomplete aneurysm occlusion were predictors of recanalization. Clinical follow-up was available for 406 patients (85.6%) for a mean of 44.8 months, and 399 patients (98.3%) achieved a Glasgow Outcome Scale score of 5.
CONCLUSIONS: Stent-assisted coiling appears to be a safe and effective option for treating complex wide-necked aneurysms. Higher complication rates are associated with coiling before stenting, use of multiple stents, and hypertension. Stent delivery before coil deployment reduces the risk of procedural complications. Larger aneurysm size and initial incomplete occlusion are associated with aneurysm recanalization.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complication; Intracranial aneurysm; Recanalization; Stent-assisted coiling

Mesh:

Year:  2016        PMID: 27424472     DOI: 10.1016/j.wneu.2016.07.017

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Stent-assisted coiling of intracranial aneurysms using LEO stents: long-term follow-up in 153 patients.

Authors:  Jacques Sedat; Yves Chau; Jean Gaudart; Marina Sachet; Stephanie Beuil; Michel Lonjon
Journal:  Neuroradiology       Date:  2017-12-23       Impact factor: 2.804

2.  Endovascular Treatment of Ruptured Middle Cerebral Artery Bifurcation Aneurysms. A Retrospective Observational Study of Short- and Long-Term Follow-Up.

Authors:  Florian Hagen; Ansgar Berlis; Martin Skalej; Christoph Johannes Maurer
Journal:  Cardiovasc Intervent Radiol       Date:  2021-01-03       Impact factor: 2.740

3.  Bleeding from an Unruptured Cerebral Aneurysm following the Local Intra-arterial Administration of Urokinase: A Case Report.

Authors:  Osamu Tone; Shoko Fujii; Yoshihiro Kubota; Yoshiaki Takada
Journal:  NMC Case Rep J       Date:  2021-08-07

4.  Five-Years Angiographic Follow-Up of Wide-Neck Intracranial Aneurysms Treated With LEO Plus Stent.

Authors:  José M Pumar; Paula Sucasas; Antonio Mosqueira; Pedro Vega; Eduardo Murias
Journal:  Front Neurol       Date:  2021-11-26       Impact factor: 4.003

5.  Endovascular Treatment of Ruptured Very Small Intracranial Aneurysms: Complications, Recurrence Rate, and Clinical Outcomes.

Authors:  Feiyun Qin; Jiaqiang Liu; Xintong Zhao; Degang Wu; Niansheng Lai; Zihuan Zhang; Zhenbao Li
Journal:  Front Neurol       Date:  2022-01-04       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.